Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Case Reports in Nephrology|March 5, 2025
Successful Use of Difelikefalin in Severe Chronic Kidney Disease-Associated Pruritus in a Patient With Complex Etiological Contributors: A Case ReportJohannes M Werzowa, Margit Hemetsberger
Future Oncology (London, England)|July 11, 2015
Denosumab for the treatment of giant cell tumor of the boneThomas Brodowicz, Margit Hemetsberger, Reinhard Windhager
Wiener Medizinische Wochenschrift (1946)|October 23, 2016
[LDL-cholesterol and cardiovascular events: the lower the better?]Raimund Weitgasser, Michaela Ratzinger, Margit Hemetsberger, et al.
Wiener Medizinische Wochenschrift (1946)|August 26, 2015
EARLIER: an observational study to evaluate the use of cinacalcet in incident hemodialysis patients with secondary hyperparathyroidism in daily clinical practiceMargit Hemetsberger, Rainer Oberbauer, Helmut Erb, et al.
Pharmaceutics|October 27, 2022
Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus IbuprofenAndré Farkouh, Margit Hemetsberger, Christian R Noe, et al.
Journal of Clinical Medicine|April 30, 2021
Sex-Related Differences in Drugs with Anti-Inflammatory PropertiesAndré Farkouh, Christoph Baumgärtel, Roman Gottardi, et al.
Wiener Klinische Wochenschrift|June 18, 2013
Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical pictureClaudia Friedl, Margit Hemetsberger, Julia Mader, et al.
Wiener Klinische Wochenschrift|December 6, 2021
Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved? : Results from the DA VINCI studyPeter Siostrzonek, Helmut Brath, Robert Zweiker, et al.
Wiener Medizinische Wochenschrift (1946)|February 1, 2014
Darbepoetin alfa once every 2 weeks effectively maintained hemoglobin in dialysis patients in an observational study: Austrian cohort of ALTERNATEWolfgang Pronai, Ulrich Neyer, Ursula Barnas, et al.
Wiener Klinische Wochenschrift|January 17, 2017
Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland - the observational TRANSIT StudyWolfgang Pronai, Alexander R Rosenkranz, Andreas Bock, et al.
Pageof 2